MHAT Dr. Ivan Seliminski AD

Sliven 8800

0 studies enrolling now · 4 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, COVID-19, Primary Sjogrens Disease, Schizophrenia

Studies at this site

• A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia — Completed
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• MP1032 Treatment in Patients With Moderate to Severe COVID-19 — Completed